📰 Complement Activation News

Complement Activation News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Complement Activation. Real-time updates on events, politics, business and more.

Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results

November 13, 2023

13.11.2023 - Company Prioritizes Greatest Near-term Value-Driving Programs: ANX005 for Guillain-Barré Syndrome (GBS), ANX007 for Geographic Atrophy (GA) and First-in-Kind Complement Small Molecule, ANX1502 ANX005 Phase 3 Pivotal Data in GBS On Track for ...

United States Sheryl Seapy Chelcie Lister American Society Of Nephrology Kidney Week European Medicines Agency Annexon Inc

Source: wallstreet-online.de

Invizius announces 'Angry Blood' Haemodialysis Study and recruits its 300th patient

June 13, 2023

/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and...

City Of United Kingdom Glasgow City Jonathan Milner Sandip Mitra Karolinska Institutet

Source: prnewswire.com

Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments

February 14, 2023

The causes of long COVID, which disables millions, may come together in the brain and nervous system

United States San Francisco Los Angeles Joanna Hellmuth Tara Ghormley Cameronk Ormiston

Source: scientificamerican.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Complement Activation News Today

Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results

Invizius announces 'Angry Blood' Haemodialysis Study and recruits its 300th patient

Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments

Explore More Categories